The Centers for Medicare and Medicaid Services aims to have all Medicare beneficiaries in a value-based arrangement by 2030. But achieving that will be a difficult undertaking, with just 12% of ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
You can trust Cyclingnews Our experts spend countless hours testing cycling tech and will always share honest, unbiased advice to help you choose. Find out more about how we test. The Giro Syntax MIPS ...
Combination creates broad portfolio of industry-focused technology offerings, adds strength to bench of SAP ® expertise and professional services talent, expands global reach and regional resources.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results